Back

Temporal trends of normal scan results and pretest probability in myocardial perfusion imaging in a tertiary referral center in Switzerland between 2000 and 2023

30 August 2025 (15:00 - 15:10)
Organised by: Logo
Congress Presentation Part of: Research highlights in nuclear cardiology Ischaemia and Viability ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Simon Frey

University Hospital Basel, Basel (Switzerland)

5 More presentations in this session

Presentation thumbnail
Visualisation and diagnostic utility for cardiovascular diseases using Biparametric Heatmap in iodine-123-beta-methyl-p-iodophenyl-pentadecanoic acid scintigraphy
Doctor H. Miyauchi (Chiba, JP)
Abstract Slides Video
Presentation thumbnail
Novel ACE2 PET imaging with 68Ga-cyc-DX600: a translational advancement for early detection and monitoring in heart failure and myocarditis
Doctor C. Wang (Shanghai, CN)
Abstract Slides Video
Presentation thumbnail
Diagnostic value of relative flow reserve in patients with prior coronary artery disease: a post-hoc analysis of the PACIFIC-2 trial
Mr R. Hoek (Amsterdam, NL)
Abstract Slides Video
Presentation thumbnail
Quantitative SPECT/CT for diagnosis of transthyretin amyloid cardiomyopathy: a pathology-based study
Doctor G. Tersalvi (Rochester, US)
Abstract Slides Video
Presentation thumbnail
Novel DPP4-targeted PET probe for non-invasive imaging of inflammatory heart in viral myocarditis
Professor X. Rao (Wuhan, CN)
Abstract Slides Video

Access the full session

Session thumbnail
Research highlights in nuclear cardiology
Video

The Event

Event poster

ESC Congress 2025

30 August 2025 15:00 CET
You may be interested in
thumbnail
Congress Session
Research highlights in nuclear cardiology
thumbnail
Congress Presentation
Diagnostic performance of clinical likelihood models to predict abnormal myocardial perfusion in patients with suspected chronic coronary syndrome
thumbnail
Congress Session
Novel non-invasive imaging of coronary artery disease

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources